Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotypes

被引:44
作者
Daly, AK
Fairbrother, KS
Andreassen, OA
London, SJ
Idle, JR
Steen, VM
机构
[1] HAUKELAND HOSP,CTR MOL MED,DR EINAR MARTENS RES GRP BIOL PSYCHIAT,N-5021 BERGEN,NORWAY
[2] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA 90033
来源
PHARMACOGENETICS | 1996年 / 6卷 / 04期
关键词
cytochrome P450; CYP2D6; polymorphism; debrisoquine;
D O I
10.1097/00008571-199608000-00005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The majority of humans deficient in the cytochrome P450 CYP2D6 enzyme, so-called poor metabolizers (PMs), can now be identified by genotyping for several different PM-associated mutations, However, additional null alleles remain to be identified as demonstrated by subjects with the PM phenotype in the absence of a corresponding genotype, The rare 11 kb band on Xba I RFLP analysis, which is distinct from the 13 kb CYP2D6D (CYP2D6*5) allele, has been proposed to constitute such a unique non-functional allele, Here we demonstrate that the 11 kb band represents at least two different nine exon CYP2D7P/CYP2D6 hybrids generated by large deletions in the CYP2D gene cluster due to unequal cross-oner or looping-out mechanisms, The total allele frequency was approximately 0.001-0.01 in European and North American Caucasians, The most common variant (CYP2D6*16) had breakpoints lying between the end of exon 7 and the start of exon 9 of the respective genes, The 'CPP2D7-like' part of the gene was most homologous to the previously described CYP2D7AP and CYP2D7(44/11.5) sequences, The other chimeric allele consisted of exon 1 of CYP2D7 and exons 2-9 from CYP2D6, and may be similar to a hybrid gene termed CYP2D6*13 recently described in a French individual, Two different routine PCR assays were developed for rapid and sensitive detection of these alleles, namely amplification of a 8 kb fragment from both CYP2D6*13 and CYP2D6*16, together with a CYP2D6*16-specific method which gave a 1.4 kb PCR product, The 8 kb assay for the CYP2D6*13 and CYP2D6*16 alleles also produced a 9.5 kb fragment in samples positive for the 13 kb CYP2D6*5 allele, Therefore, it is now possible to screen for the large CYP2D gene deletions by a single long PCR method.
引用
收藏
页码:319 / 328
页数:10
相关论文
共 24 条
  • [1] HYDROXYLATION POLYMORPHISMS OF DEBRISOQUINE AND MEPHENYTOIN IN EUROPEAN POPULATIONS
    ALVAN, G
    BECHTEL, P
    ISELIUS, L
    GUNDERTREMY, U
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) : 533 - 537
  • [2] An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis
    Broly, F
    Marez, D
    Sabbagh, N
    Legrand, M
    Millecamps, S
    LoGuidice, JM
    Boone, P
    Meyer, UA
    [J]. PHARMACOGENETICS, 1995, 5 (06): : 373 - 384
  • [3] DEBRISOQUINE SPARTEINE HYDROXYLATION GENOTYPE AND PHENOTYPE - ANALYSIS OF COMMON MUTATIONS AND ALLELES OF CYP2D6 IN A EUROPEAN POPULATION
    BROLY, F
    GAEDIGK, A
    HEIM, M
    EICHELBAUM, M
    MORIKE, K
    MEYER, UA
    [J]. DNA AND CELL BIOLOGY, 1991, 10 (08) : 545 - 558
  • [4] THE ROLE OF INDIVIDUAL HUMAN CYTOCHROMES-P450 IN DRUG-METABOLISM AND CLINICAL-RESPONSE
    CHOLERTON, S
    DALY, AK
    IDLE, JR
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (12) : 434 - 439
  • [5] GENETIC AND METABOLIC CRITERIA FOR THE ASSIGNMENT OF DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P4502D6) PHENOTYPES
    DALY, AK
    ARMSTRONG, M
    MONKMAN, SC
    IDLE, ME
    IDLE, JR
    [J]. PHARMACOGENETICS, 1991, 1 (01): : 33 - 41
  • [6] DALY AK, 1995, HUM GENET, V95, P337
  • [7] Nomenclature for human CYP2D6 alleles
    Daly, AK
    Brockmoller, J
    Broly, F
    Eichelbaum, M
    Evans, WE
    Gonzalez, FJ
    Huang, JD
    Idle, JR
    IngelmanSundberg, M
    Ishizaki, T
    JacqzAigrain, E
    Meyer, UA
    Nebert, DW
    Steen, VM
    Wolf, CR
    Zanger, UM
    [J]. PHARMACOGENETICS, 1996, 6 (03): : 193 - 201
  • [8] EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V17, P153
  • [9] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION
    EVANS, DAP
    MAHGOUB, A
    SLOAN, TP
    IDLE, JR
    SMITH, RL
    [J]. JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) : 102 - 105
  • [10] THE GENETIC-CONTROL OF SPARTEINE AND DEBRISOQUINE METABOLISM IN MAN WITH NEW METHODS OF ANALYZING BIMODAL DISTRIBUTIONS
    EVANS, DAP
    HARMER, D
    DOWNHAM, DY
    WHIBLEY, EJ
    IDLE, JR
    RITCHIE, J
    SMITH, RL
    [J]. JOURNAL OF MEDICAL GENETICS, 1983, 20 (05) : 321 - 329